drugset / Trial / NCT04242927

A Study to Investigate Nicotinic Acid on VEGFR Inhibitor-Associated Hand-Foot Skin Reactions

NCT04242927

RandomizedParallel-groupQuadruple-blindSupportive care

Summary

Hand-Foot Skin Reaction (HFSR) is a common adverse event induced by Vascular Endothelial Growth Receptor Inhibitor (VEGFRi) in cancer patients. The main purpose of this study is to evaluate the efficacy and safety of nicotinic acid in solid tumor patients with grade II/III VEGFRi-associated HFSR.

Timeline

Start
2020-03-09
Primary completion
2021-03-09
Completion
2022-03-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Niacin Small molecule 50 mg Oral
Subject Niacin Small molecule 100 mg Oral

Indications